References
- American Cancer Society. Signs and Symptoms of Oral Cavity and Oropharyngeal Cancer. [cited 2020 Mar 12]. Available from: https://www.cancer.org/cancer/oral-cavity-and-oropharyngeal-cancer/detection-diagnosis-staging/signs-symptoms.html. Published 2018.
- Simard EP, Torre LA, Jemal A, et al. International trends in head and neck cancer incidence rates: Differences by country, sex and anatomic site. Oral Oncol. 2014;50(5):387–403.
- Jakobsen KK, Grønhøj C, Jensen DH, et al. Increasing incidence and survival of head and neck cancers in Denmark: a nation-wide study from 1980 to 2014. Acta Oncol. 2018;57(9):1143–1151.
- Schutte HW, Heutink F, Wellenstein DJ, et al. Impact of time to diagnosis and treatment in head and neck cancer: a systematic review. Otolaryngol Head Neck Surg. 2020;162(4):446–457.
- Coca-Pelaz A, Takes RP, Hutcheson K, et al. Head and neck cancer: a review of the impact of treatment delay on outcome. Adv Ther. 2018;35(2):153–160.
- Danish Health Authority. Cancer Pathways. [cited 2019 Sep 24]. Available from: https://www.sst.dk/en/national-clinical-guidelines.
- Schmidt Jensen J, Jakobsen KK, Mirian C, et al. The Copenhagen Oral Cavity Squamous Cell Carcinoma database: protocol and report on establishing a comprehensive oral cavity cancer database. Clin Epidemiol. 2019;11:733–741.
- Thygesen LC, Daasnes C, Thaulow I, et al. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health. 2011;39(7 Suppl):12–16.
- R Core Team. R: A language and environment for statistical computing. 2017. Available from: https://www.r-project.org/.
- Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169–178.
- Grønhøj C, Jensen D, Dehlendorff C, et al. Impact of time to treatment initiation in patients with Human Papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma. Clin Oncol. 2018;30(6):375–381.
- van Harten M, Hoebers FJP, Kross KW, et al. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015;51(3):272–278.
- Caudell JJ, Locher JL, Bonner JA. Diagnosis-to-treatment interval and control of locoregionally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2011;137(3):282–285.
- Barton MB, Morgan G, Smee R, et al. Does waiting time affect the outcome of larynx cancer treated by radiotherapy? Radiother Oncol. 1997;44(2):137–141.
- Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84(1):5–10.
- Waaijer A, Terhaard CHJ, Dehnad H, et al. Waiting times for radiotherapy: Consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003;66(3):271–276.
- Kowalski LP, Carvalho AL. Influence of time delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncol. 2001;37(1):94–98.
- Wildt J, Bundgaard T, Bentzen SM. Delay in the diagnosis of oral squamous cell carcinoma. Clin Otolaryngol Allied Sci. 1995;20(1):21–25.
- Crawford SC, Davis JA, Siddiqui NA, et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ. 2002;325(7357):196.